Chemoinformaics analysis of D-(+)-Carvone
Molecular Weight | 150.221 | nRot | 1 |
Heavy Atom Molecular Weight | 136.109 | nRig | 8 |
Exact Molecular Weight | 150.104 | nRing | 1 |
Solubility: LogS | -1.916 | nHRing | 0 |
Solubility: LogP | 2.136 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 25 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 26.8371 |
nHD | 0 | BPOL | 14.9129 |
QED | 0.524 |
Synth | 4.094 |
Natural Product Likeliness | 2.672 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.002 |
HIA | 0.005 |
CACO-2 | -4.366 |
MDCK | 0.0000279 |
BBB | 0.99 |
PPB | 0.529627 |
VDSS | 0.84 |
FU | 0.393481 |
CYP1A2-inh | 0.126 |
CYP1A2-sub | 0.816 |
CYP2c19-inh | 0.051 |
CYP2c19-sub | 0.824 |
CYP2c9-inh | 0.022 |
CYP2c9-sub | 0.211 |
CYP2d6-inh | 0.013 |
CYP2d6-sub | 0.734 |
CYP3a4-inh | 0.1 |
CYP3a4-sub | 0.291 |
CL | 13.606 |
T12 | 0.766 |
hERG | 0.005 |
Ames | 0.029 |
ROA | 0.061 |
SkinSen | 0.041 |
Carcinogencity | 0.432 |
EI | 0.912 |
Respiratory | 0.694 |
NR-Aromatase | 0.005 |
Antiviral | No |
Prediction | 0.921663 |